Product
Autologous or Syngeneic PBTLs and EBV-CTLs
1 clinical trial
2 indications
Indication
Non-Hodgkin lymphomaIndication
Chronic Lymphocytic LeukemiaClinical trial
Phase I Study Of The Administration Of Peripheral Activated T-Cells and EBV Specific CTLs Expressing CD19 Chimeric Receptors For Advanced B-Cell Non-Hodgkin's Lymphoma And Chronic Lymphocytic Leukemia (ATECRAB)Status: Active (not recruiting), Estimated PCD: 2012-05-01